Allergy Therapeutics (LON:AGY) Stock Crosses Below 200-Day Moving Average – Here’s What Happened

Allergy Therapeutics plc (LON:AGY)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 6.66 ($0.09) and traded as low as GBX 6.50 ($0.09). Allergy Therapeutics shares last traded at GBX 6.77 ($0.09), with a volume of 1,126,674 shares traded.

Allergy Therapeutics Stock Up 4.3%

The company’s 50 day moving average price is GBX 6.89 and its two-hundred day moving average price is GBX 6.66. The firm has a market cap of £358.80 million, a PE ratio of -7.04, a PEG ratio of -30.70 and a beta of 1.40. The company has a current ratio of 1.63, a quick ratio of 1.48 and a debt-to-equity ratio of 835.48.

Allergy Therapeutics (LON:AGY) last issued its quarterly earnings results on Monday, March 31st. The company reported GBX (0.23) ($0.00) earnings per share for the quarter. Allergy Therapeutics had a negative return on equity of 266.59% and a negative net margin of 72.86%. On average, equities research analysts expect that Allergy Therapeutics plc will post -2.56 EPS for the current fiscal year.

Allergy Therapeutics Company Profile

Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.